Skip to content

Effects of the different doses of Oliceridine on postoperative quality of recovery in patients undergoing laparoscopic cholecystectomy

Effects of the different doses of Oliceridine on postoperative quality of recovery in patients undergoing laparoscopic cholecystectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081760
Enrollment
Unknown
Registered
2024-03-11
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic cholecystectomy

Interventions

Low dose Oliceridine group (O1 group): Oliceridine 0.01mg/kg was given intravenously at the end of the operation
High dose Oliceridine group (O2 group):Oliceridine 0.05mg/kg was given intravenously at the end of the operation
Sufentanil group (S group):Sufentanil 0.1ug/kg was administered intravenously at the end of the procedure
Control group (Group C):The same amount of 0.9% sodium chloride solution was injected intravenously at the end of the operation

Sponsors

The People’s Hospital of Yubei District, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic cholecystectomy in our hospital; 2. All anesthesia methods are general anesthesia; 3. ASA grade I ~ II; 4, age 18 to 65 years old; 5, 18 kg/m^2=BMI=35kg/m^2; 6. Know the research content and sign the research informed consent voluntarily;

Exclusion criteria

Exclusion criteria: 1. Allergic to Oliceridine or sufentanil; 2. Long-term use of other opioids or analgesics; 3. Patients with a history of severe heart, liver and kidney disease, diabetes and severe hypertension, and whose condition is not controlled; 4. People with cognitive disabilities; 5, BMI> 35 kg/m2; 6. Duration of operation is > 2.5 hours; 7. Hemodynamic instability or respiratory insufficiency.

Design outcomes

Primary

MeasureTime frame
The Quality of Recovery Score-40(QoR-40);

Secondary

MeasureTime frame
Recovery time;Cough score;NRS pain score;PONV score;

Countries

China

Contacts

Public ContactBigao Deng

The People’s Hospital of Yubei District, Chongqing

63718310@qq.com+86 138 9648 1189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026